Delivery Order SPE2DB20D1050-SPE2DB24FH59Y
Award Date 4/9/24
Potential Completion Date 4/10/24
Potential Value $2.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $47,359.72 contract is for the supply of RESTASIS 0.05% eye emulsion to support military treatment programs and facilities. This order does not fall under any set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product, with a ceiling value of $2,124.48 and a performance period through April 4, 2024. This delivery order is issued under a single-award indefinite delivery contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $6,331.55, is for the provision of RESTASIS 0.05% eye emulsion. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,820.38 firm fixed-price delivery order is for RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,786.41 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RESTASIS 0.05% eye emulsion. This award, which does not have a set-aside designation, is for delivery by January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the delivery order was issued under an indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RESTASIS 0.05% eye emulsion. The $34,149.58 firm-fixed-price contract has a completion date of May 24, 2024. No set-aside designation was used. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Restasis 0.05% eye emulsion. The contract has a ceiling value of $7,331.28 and a period of performance through March 9, 2022. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the provision of Restasis 0.05% eye emulsion. The $5,099.73 firm fixed price contract has a performance period through May 23, 2022. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This is a delivery order under a contract with the Defense Logistics Agency (DLA) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Restasis 0.05% eye emulsion, a prescription eye medication, with a ceiling value of $8,841.64. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RESTASIS 0.05% eye emulsion. The contract is a firm fixed-price delivery order with a ceiling value of $9,145.24 and a period of performance through April 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The award is not designated with any set-aside...